Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Berger

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|June 5, 1976
Letter: Bacloffen in schizophreniaK L Davis, L E Hollister, P A Berger
Archives of General Psychiatry|November 1, 1976
Pituitary response to thyrotropin-releasing hormone in depressionL E Hollister, K L Davis, P A Berger
Archives of General Psychiatry|October 1, 1980
Subtypes of depression based on excretion of MHPG and response to nortriptylineL E Hollister, K L Davis, P A Berger
Archives of General Psychiatry|January 1, 1987
Abnormal rapid eye movement latencies in schizophreniaV P Zarcone, K L Benson, P A Berger
Psychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E Hollister
The New England Journal of Medicine|July 17, 1975
Letter: Choline for tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Biological Psychiatry|October 1, 1985
Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatientsS M Stahl, S B Uhr, P A Berger
The Journal of Nervous and Mental Disease|March 1, 1978
Single case study. Possible organophosphate-induced parkinsonismK L Davis, J A Yesavage, P A Berger
Advances in Biochemical Psychopharmacology|January 1, 1982
Platelet serotonin in schizophrenia and depressionS M Stahl, R D Ciaranello, P A Berger
The Journal of Clinical Psychiatry|November 1, 1982
Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesiaS M Stahl, J A Yesavage, P A Berger
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|June 5, 1976
Letter: Bacloffen in schizophreniaK L Davis, L E Hollister, P A Berger
Archives of General Psychiatry|November 1, 1976
Pituitary response to thyrotropin-releasing hormone in depressionL E Hollister, K L Davis, P A Berger
Archives of General Psychiatry|October 1, 1980
Subtypes of depression based on excretion of MHPG and response to nortriptylineL E Hollister, K L Davis, P A Berger
Archives of General Psychiatry|January 1, 1987
Abnormal rapid eye movement latencies in schizophreniaV P Zarcone, K L Benson, P A Berger
Psychopharmacology Communications|January 1, 1976
Tardive dyskinesia and depressive illnessK L Davis, P A Berger, L E Hollister
The New England Journal of Medicine|July 17, 1975
Letter: Choline for tardive dyskinesiaK L Davis, P A Berger, L E Hollister
Biological Psychiatry|October 1, 1985
Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatientsS M Stahl, S B Uhr, P A Berger
The Journal of Nervous and Mental Disease|March 1, 1978
Single case study. Possible organophosphate-induced parkinsonismK L Davis, J A Yesavage, P A Berger
Advances in Biochemical Psychopharmacology|January 1, 1982
Platelet serotonin in schizophrenia and depressionS M Stahl, R D Ciaranello, P A Berger
The Journal of Clinical Psychiatry|November 1, 1982
Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesiaS M Stahl, J A Yesavage, P A Berger
Pageof 14